The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial

The aim of the HYLAN M study was to investigate if symptoms and/or signs of patients suffering from severe dry eye disease (DED) can be improved by substituting individually optimized artificial tear therapy by high molecular weight hyaluronan (HMWHA) eye drops. In this international, multicenter st...

Descripción completa

Detalles Bibliográficos
Autores principales: van Setten, Gysbert-Botho, Baudouin, Christophe, Horwath-Winter, Jutta, Böhringer, Daniel, Stachs, Oliver, Toker, Ebru, Al-Zaaidi, Sultan, Benitez-del-Castillo, Jose M., Beck, Ria, Al-Sheikh, Osama, Seitz, Berthold, Barabino, Stefano, Reitsamer, Herbert A., Müller-Lierheim, Wolfgang G.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693312/
https://www.ncbi.nlm.nih.gov/pubmed/33147751
http://dx.doi.org/10.3390/jcm9113536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693312/
https://www.ncbi.nlm.nih.gov/pubmed/33147751
http://dx.doi.org/10.3390/jcm9113536

Ejemplares similares